ReviewFrontiers in public health2026
Multidimensional correlation magnetic resonance imaging in low- and middle-income countries: opportunities and barriers to equitable deployment.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multidimensional Correlation Magnetic Resonance Imaging (McMRI) represents a promising advancement in medical imaging, offering enhanced diagnostic accuracy through the integration of multiple MRI parameters into unified datasets. In low- and middle-income countries (LMICs), McMRI could significantly improve early disease detection and treatment planning, particularly for complex conditions such as cancer and neurological disorders. Benefits include richer data acquisition, improved tissue characterization, and the potential for cost-effective, non-invasive diagnostics. However, practical barriers remain: limited infrastructure, scarcity of trained personnel, high implementation costs, unstable power supply, and data governance challenges hinder widespread adoption. Addressing these issues requires efficient computational workflows, sustainable technology investment, and capacity-building initiatives tailored to LMIC contexts. This review highlights both the transformative potential and the practical obstacles of deploying McMRI in resource-constrained settings, underscoring the need for collaborative strategies that align technological innovation with healthcare equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.